Prof. Jakub Gołąb for hematoonkologia.pl

Professor Jakub Golab ( MUW ) of the BASTION Project in an interview for the hematoonkologia.pl poratl talked about cancer immunotherapy . Professor Jakub Golab: “I regret that in Poland there is no university course of study related medical chemistry . We don’t have a sufficient number of specialists in this country, a few we have […] ›


Dr. Pawel Gaj and dr. Radoslaw Zagozdzon published a research letter in the Breast Cancer Research journal on the clinical relevance of miR-510 in breast cancer

A Breast Cancer Research journal letter “In silico analysis of microRNA-510 as a potential oncomir in human breast cancer” has been published on March 12th 2014. The authors provide the context of -omics type population-centered in silico analysis to discuss a previously published information on a putative oncogenic character of miR-510 effects. The published results […] ›


The latest paper of prof Jakub Golab MD, PhD on the antitumor effect of photodynamic therapy

On February 18th in European Journal of Cancer (EJC) an articleentitled 5-Aza-2’-deoxycytidine potentiates antitumor immune response induced by photodynamic therapy has been published. The study was focused on  antitumor effect of photodynamic therapy combined with 5-aza-2’-deoxycytidine, a methyltransferase inhibitor. Our observation suggest that clinically approved epigenetic agent 5-aza-2’-deoxycytidine can improve PDT induced antitumor immune response leading to […] ›


Obserwuj nas na Twitterze